Document is current

Article History

Received: 6 March 2025

Accepted: 20 May 2025

First Online: 25 May 2025

Declarations

:

: The authors declare no competing interests.

: Our study exclusively involves patient-derived cells without any associated clinical data. According to the ethical regulations of our institution and French law (Article L.1211-2 al.2 du Code de la santé publique), such research does not require Institutional Review Board (IRB) approval. Additionally, as per our institutional policy, all patients systematically sign a non-opposition statement, allowing the use of their biological samples for research purposes. Indeed, all patients included in the study were informed via the CHU Clermont-Fd welcome booklet that the remaining biological samples taken during their diagnosis and follow-up could be used for research unless they objected; no patient expressed their objection. All methods were carried out in accordance with relevant guidelines and regulations.